We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

11 hedge funds and large institutions have $894K invested in Arcadia Biosciences in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.3% less ownership

Funds ownership: 9.2% → 5.9% (-3.3%)

15% less funds holding

Funds holding: 13 → 11 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

67% less capital inflows, than outflows

Capital inflows: $330K | Capital outflows: $1.01M

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Anson Funds Management
Anson Funds Management
Texas
+$232K
2
Oxford Asset Management
Oxford Asset Management
United Kingdom
+$93.6K
3
Virtu Financial
Virtu Financial
New York
+$4.03K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$763K
2
Wells Fargo
Wells Fargo
California
-$106K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$67K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$63K
5
Morgan Stanley
Morgan Stanley
New York
-$9.08K

RKDA Hedge Fund Activity: Q4 2018 in Review

11 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2018, worth a combined $894K — down 58% from $2.14M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RKDA and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $232K. The largest seller was Sabby Management, cutting an estimated $763K.

  • 11 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2018, down from 13 in Q3 2018.
  • Funds reported $894K of Arcadia Biosciences stock for Q4 2018, down 58% quarter-over-quarter.
  • 2 funds opened new Arcadia Biosciences positions in Q4 2018 and 4 closed out, a net change of -2 holders.
  • The largest Arcadia Biosciences buyer in Q4 2018 was Anson Funds Management, an estimated $232K added.
  • The largest Arcadia Biosciences seller in Q4 2018 was Sabby Management, an estimated $763K sold.

Based on aggregated 13F filings for Q4 2018.